明泰鋁業(601677.SH):“年產70萬噸綠色新型鋁合金材料項目”及“年產25萬噸新能源電池材料項目”進展順利
格隆匯2月15日丨明泰鋁業(601677.SH)於2月8日、2月13日、2月14日接受機構現場調研時表示,公司產品在新能源電池領域主要包含電池箔、鋁塑膜箔、電子箔、釺焊複合水冷板、pack包、電池殼、電池托盤等。
公司非常重視新能源領域產品開發,本年度銷售部門成立了新能源產品開發小組,持續加大新能源領域產品開發,改善產品結構。全資子公司義瑞新材“年產70萬噸綠色新型鋁合金材料項目”及“年產25萬噸新能源電池材料項目”進展順利,項目投產後新能源產品佔比將大幅提升,產品結構進一步改善,提升公司盈利空間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.